Хроническую венозную недостаточность не всегда относят к общепринятым факторам риска кардиальных осложнений (возраст, дислипидемия, артериальная гипертензия и пр.).Целью настоящего исследования явилась оценка взаимосвязи между хронической венозной недостаточностью в системе нижней полой вены, в т.ч. на фоне кардиометаболических изменений и неблагоприятными артериальными событиями.В статье осуществлено сравнение последствий хронической венозной недостаточности в случае отсутствия венозных тромбозов и наличия тромботических осложнений. Прослежены отдаленные результаты в сроки до 3-х лет. Проанализированы факторы риска тромботических осложнений, признаки асимптомного атеросклероза и неблагоприятные кардиоваскулярные события. По итогам исследования выявлены ассоциации между венозными тромбозами и кардиометаболическими факторами риска, а также асимптомным атероматозом, неблагоприятными кардиоваскулярными событиями, что позволило сделать вывод о значимости профилактических мероприятий у лиц с венозными тромбозами.
Chronic venous insufficiency is not always considered to be common risk factors for cardiac complications (age, dyslipidemia, hypertension, etc.).The purpose of this research was to evaluate the relationship between chronic venous insufficiency in the vena cava inferior and adverse arterial events because of cardiometabolicchanges.The comparison of patients with chronic venous insufficiency in case of absence of venous thrombosis and the presence of thrombotic complications is presented in the article. Long-term results in terms of up to 3 years are traced. Risk factors for thrombotic complications, signs of asymptomatic atherosclerosis and adverse cardiovascular events were analyzed.According to the research, an association between venous thrombosis and cardiometabolic risk factors, and also asymptomatic atheromatosis, adverse cardiovascular events were revealed, which made it possible to conclude about the importance of preventive measures in patients with venous thrombosis.
1. Ageno, W., Prandoni, P., Romualdi, E. et al. The metabolic syndrome and the risk of venous thrombosis: a case-control study // J ThrombHaemost. – 2006. – V. 4. – P. 1914-1918.
2. Agnelli, G., Becattini,C.. Venous thromboembolism and atherosclerosis: common denominators or different diseases? // J ThrombHaemost. – 2006. – V. 4. – N 9. – P. 1886-1890.
3. Grundy, S.M., Cleeman,J..I, Daniels, S.R.et al. Diagnosis and management of the metabolic syndrome: an American Heart Association // National Heart, Lung, and Blood Institute Scientific Statement. Circulation. – 2005. – V. 112. – P. 2735-2752.
4. Milan, M., Vedovetto, V., Bilora, F. et al. Further evidence in support of the association between venous thrombosis and atherosclerosis: a case-control study // Thromb Res. – 2014. – V. 134. – N 5. – P. 1028-1031.
5. Ray, J.G., Rosendaal, F.R. The role of dyslipidemia and statins in venous thromboembolism // Curr Control Trials Cardiovasc Med. – 2001. – V. 2. – P. 165-170.
6. Rosendaal, F.R. Risk factors for venous thrombosis: prevalence, risk, and interaction // SeminHematol. – 1997. –V. 34. – P. 171-187.
7. Tsai, A.W., Cushman, M., Rosamond, W.D. et al. Cardiovascular risk factors and venous thromboembolism incidence: the longitudinal investigation of thromboembolism etiology // Arch Intern Med. – 2002. – V. 162. – P. 1182-1189.
8. Ross, R. The pathogenesis of atherosclerosis: a perspective for the 1990s // Nature. – 1993. –V. 362. – P. 801-
9. Woodward, M., Lowe, G.D.O., Rumley, A. et al. Epidemiology of coagulation factors, inhibitors and activation markers: the Third Glasgow MONICA Survey Relationships to cardiovascular risk factors and prevalent cardiovascular disease // British Journal of Haematology.– 1997. – V.97. – P. 785 –797.
10. Yusuf, H.R., Reyes, N., Zhang, Q.C. et al. Hospitalizations of adults ≥60 years of age with venous thromboembolism // Clinapplthrombhemost. – 2014. – V. 20. – P. 136-142.